Findings of EU Project On Conservation Of Genetic Resources Due Out In June 07/03/2016 by Intellectual Property Watch 2 Comments The findings, conclusions and preliminary recommendations of a European Commission initiative on the conservation and sustainable use of genetic diversity are to be presented in June, the Commission has announced.
TRIPS Council: Differing Views On IP Education; New Database Project Launched 04/03/2016 by Catherine Saez, Intellectual Property Watch 1 Comment Discussions on the worth of intellectual property for innovation and development have been a recurring agenda item during recent meetings of the World Trade Organization committee on intellectual property. This week, education and how it can raise awareness of IP was discussed with WTO members presenting their national experiences, and some developing countries warning against colluding IP and innovation.
Apple-FBI Case Has “Serious Global Ramifications,” UN Human Rights Chief Says 04/03/2016 by Intellectual Property Watch 1 Comment The United Nations High Commissioner for Human Rights, Zeid Ra’ad Al Hussein, today issued a statement urged United States law enforcement authorities to exercise caution in their legal fight against Apple computer company, saying it could have “extremely damaging implications for the human rights of many millions of people, including their physical and financial security.”
WHO To Hold Stakeholder Consultation On Status Of Zika Research Next Week 04/03/2016 by Intellectual Property Watch 1 Comment The World Health Organization has announced it will hold a closed-door, three-day consultation with key stakeholders next week in Geneva to discuss the current status of clinical research into the Zika virus.
Alleged R&D Costs: Not A Transparent Driver Of Drug Prices 04/03/2016 by Intellectual Property Watch 3 Comments Whether laws enforcing transparency on costs would help curb extortionate drug prices in today’s world is hardly predictable now that pharma companies and their allies are lobbying governments to scupper any rules that would require them to disclose the real R&D costs and profits of their medicines and the rationale for charging what they do, writes Daniele Dionisio.
European Patents Rising; EPO President Denies Retirement Package 03/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment BRUSSELS — Patents applications are on the rise in Europe the European Patent Office President Benoît Battistelli said today, with half of the applications coming from European inventors. The United States led followed by Germany, and Japan, and China showing a strong growth. The EPO president also announced the signature of an agreement with one trade union against a background of social unrest in the organisation.
IEEE Patent Policy Changes Seek To Put Brakes On Surging Litigation 03/03/2016 by Dugie Standeford for Intellectual Property Watch Leave a Comment Intense debate, reignited by a 2012 International Telecommunication Union roundtable on rampant patent litigation and the “innovation-stifling” use of intellectual property, together with the growing lack of standards bodies’ patent policies, prompted the IEEE Standards Association (IEEE) last year to revisit parts of its patent policy that had been causing some concerns, Managing Director Konstantinos Karachalios said at a 17 February Oxfirst webinar. The changes aim to clear up some ambiguities. Perhaps predictably, however, some pushback has arisen among industries affected by the change.
TPP Is Obama’s Top Trade Priority For 2016 02/03/2016 by Intellectual Property Watch 1 Comment Passage of the Trans-Pacific Partnership agreement is the Obama administration’s top trade priority this year, the Office of the United States Trade Representative said in its annual trade agenda released today. The agenda highlights intellectual property protection but also says all the right things on copyright limitations and exceptions, safe harbor for internet service providers, and the ability of countries to use flexibilities under international trade law.
Uganda In Clinical Trials For Ebola Vaccine 02/03/2016 by Hillary Muheebwa for Intellectual Property Watch 1 Comment KAMPALA, Uganda — An Ebola vaccine trial is underway in Uganda, as the global search for an effective vaccine continues. The vaccine candidate was co-developed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), and GlaxoSmithKline (GSK), a United Kingdom-based pharmaceutical company.
CETA Legal Review Completed, Now Off To Parliaments And Governments For Approval 01/03/2016 by Monika Ermert for Intellectual Property Watch 1 Comment The European Union and Canada have jointly announced the finalisation of the legal review for Canada-European Union Comprehensive Economic and Trade Agreement (CETA).